Currus Biologics Company
Currus Biologics is a biotechnology company that develop CAR-T cell therapies for the treatment of solid tumour cancers.
Technology:
CAR-T
Industry:
Private
Headquarters:
Melbourne, Victoria, Australia
Founded Date:
2020-01-01
Employees Number:
1-10
Funding Status:
Early Stage Venture
Investors Number:
2
Total Funding:
10000000
Last Funding Date:
2021-06-29
Last Funding Type:
Series A
Register and Claim Ownership